• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

永久性心房颤动心力衰竭患者的全身血管阻力的预后价值:一项回顾性研究。

The prognostic value of systemic vascular resistance in heart failure patients with permanent atrial fibrillation: a retrospective study.

机构信息

Department of Cardiology, Aoyang Hospital Affiliated to Jiangsu University, Zhangjiagang, 215600, China.

出版信息

Heart Vessels. 2023 Dec;38(12):1431-1441. doi: 10.1007/s00380-023-02314-0. Epub 2023 Sep 25.

DOI:10.1007/s00380-023-02314-0
PMID:37743357
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10603009/
Abstract

Heart failure (HF) and permanent atrial fibrillation (AF) interact mutually, exacerbating hemodynamic effects and causing adverse outcomes and increased healthcare costs. Monitoring hemodynamic indicators in patients with these comorbidities is crucial for effective clinical management. Transthoracic impedance cardiography (ICG) has been widely employed in assessing hemodynamic status in clinical settings. Given the limited research on the prognostic significance of ICG parameters in HF with permanent AF, we undertook this study. A total of 66 HF patients with permanent AF were included in this retrospective study, and the primary outcome was rehospitalization due to worsening HF within 180-day post-discharge. Cox regression analysis was performed to explore the connection between ICG-evaluated parameters and the outcome risk. Receiver operating characteristic (ROC) curve analysis determined the optimal cutoff values of risk factors, subsequently applied in plotting Kaplan Meier (KM) survival curves. Multivariate Cox regression analysis revealed that systemic vascular resistance (SVR) both on admission and at discharge independently predicted rehospitalization for worsening HF. ROC analysis established optimal SVR cutoff values: 320.89 (kPa s/L) on admission and 169.94 (kPa s/L) at discharge (sensitivity 70%, specificity 94.4%, area under the curve (AUC) 0.831, respectively, sensitivity 90%, specificity 55.6%, AUC 0.742). KM survival curves analysis showed that patients with SVR > 320.89 (kPa s/L) on admission had an 8.14-fold (P < 0.001) increased risk of the end-point event compared with those with SVR ≤ 320.89 (kPa s/L). Similarly, patients with SVR > 169.94 (kPa s/L) at discharge faced a risk elevated by 6.57 times (P = 0.002) relative to those with SVR ≤ 169.94 (kPa s/L). In HF patients with permanent AF, SVR measured by ICG emerges as an independent risk factor and clinical predictor for HF deterioration-related readmission within 180 days after discharge. Higher SVR levels, both upon admission and at discharge, correlate with an incremental rehospitalization risk.

摘要

心力衰竭(HF)和永久性心房颤动(AF)相互作用,加重血液动力学效应,导致不良后果和增加医疗保健成本。监测这些合并症患者的血液动力学指标对于有效的临床管理至关重要。经胸阻抗心动图(ICG)已广泛应用于临床评估血液动力学状态。鉴于在永久性 AF 的 HF 中 ICG 参数的预后意义的研究有限,我们进行了这项研究。这项回顾性研究共纳入了 66 例 HF 合并永久性 AF 的患者,主要结局是出院后 180 天内因 HF 恶化而再次住院。采用 Cox 回归分析探讨 ICG 评估参数与结局风险之间的关系。受试者工作特征(ROC)曲线分析确定危险因素的最佳截断值,随后用于绘制 Kaplan-Meier(KM)生存曲线。多变量 Cox 回归分析显示,入院时和出院时的全身血管阻力(SVR)均独立预测因 HF 恶化而再次住院。ROC 分析确定了最佳 SVR 截断值:入院时为 320.89(kPa s/L),出院时为 169.94(kPa s/L)(敏感性 70%,特异性 94.4%,曲线下面积(AUC)为 0.831,敏感性 90%,特异性 55.6%,AUC 为 0.742)。KM 生存曲线分析显示,入院时 SVR > 320.89(kPa s/L)的患者与 SVR ≤ 320.89(kPa s/L)的患者相比,终点事件的风险增加了 8.14 倍(P < 0.001)。同样,出院时 SVR > 169.94(kPa s/L)的患者与 SVR ≤ 169.94(kPa s/L)的患者相比,风险增加了 6.57 倍(P = 0.002)。在 HF 合并永久性 AF 的患者中,ICG 测量的 SVR 是出院后 180 天内 HF 恶化相关再入院的独立危险因素和临床预测因素。入院时和出院时较高的 SVR 水平与再入院风险增加相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8464/10603009/9bfbcda1c259/380_2023_2314_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8464/10603009/afff3c6954f5/380_2023_2314_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8464/10603009/1de1c32de95a/380_2023_2314_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8464/10603009/ce817e45c1fc/380_2023_2314_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8464/10603009/9bfbcda1c259/380_2023_2314_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8464/10603009/afff3c6954f5/380_2023_2314_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8464/10603009/1de1c32de95a/380_2023_2314_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8464/10603009/ce817e45c1fc/380_2023_2314_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8464/10603009/9bfbcda1c259/380_2023_2314_Fig4_HTML.jpg

相似文献

1
The prognostic value of systemic vascular resistance in heart failure patients with permanent atrial fibrillation: a retrospective study.永久性心房颤动心力衰竭患者的全身血管阻力的预后价值:一项回顾性研究。
Heart Vessels. 2023 Dec;38(12):1431-1441. doi: 10.1007/s00380-023-02314-0. Epub 2023 Sep 25.
2
Clinical characteristics and predictors of one-year outcome of heart failure patients with atrial fibrillation compared to heart failure patients in sinus rhythm.与窦性心律心力衰竭患者相比,心房颤动心力衰竭患者的临床特征及一年期预后预测因素
Kardiol Pol. 2016;74(3):251-61. doi: 10.5603/KP.a2015.0180. Epub 2015 Sep 14.
3
Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial Fibrillation.在有房颤病史的患者中,新发心力衰竭的预测因素及其预后意义。
JACC Heart Fail. 2017 Jan;5(1):44-52. doi: 10.1016/j.jchf.2016.09.016.
4
Prognostic impact of new-onset atrial fibrillation associated with worsening heart failure in aging patients with severely decompensated acute heart failure.新出现的心房颤动对老年重度失代偿性急性心力衰竭患者心力衰竭恶化的预后影响。
Int J Cardiol. 2020 Mar 1;302:88-94. doi: 10.1016/j.ijcard.2019.09.020. Epub 2019 Sep 13.
5
High molecular weight fibroblast growth factor-2 as a promising prognostic biomarker to predict the occurrence of heart failure in atrial fibrillation patients.高分子量成纤维细胞生长因子-2作为预测心房颤动患者心力衰竭发生的一种有前景的预后生物标志物。
Heart Vessels. 2017 Dec;32(12):1506-1512. doi: 10.1007/s00380-017-1019-y. Epub 2017 Jul 8.
6
Catheter ablation of atrial fibrillation reduces heart failure rehospitalization in patients with heart failure with preserved ejection fraction.导管消融治疗心房颤动可降低射血分数保留心力衰竭患者心力衰竭再住院率。
J Cardiovasc Electrophysiol. 2020 Mar;31(3):682-688. doi: 10.1111/jce.14369. Epub 2020 Jan 31.
7
Atrial fibrillation is an independent risk factor for heart failure hospitalization in heart failure with preserved ejection fraction.心房颤动是射血分数保留的心力衰竭患者心力衰竭住院的独立危险因素。
ESC Heart Fail. 2022 Oct;9(5):2918-2927. doi: 10.1002/ehf2.13836. Epub 2022 Jun 16.
8
Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction.心力衰竭伴射血分数降低患者的房颤类型与结局。
J Am Coll Cardiol. 2017 Nov 14;70(20):2490-2500. doi: 10.1016/j.jacc.2017.09.027.
9
Weekend vs. weekday admission and clinical outcomes in heart failure patients with and without atrial fibrillation in Taiwan.台湾地区伴或不伴心房颤动的心力衰竭患者周末与工作日入院与临床结局的比较。
Eur Heart J Cardiovasc Pharmacother. 2022 Jun 8;8(4):346-352. doi: 10.1093/ehjcvp/pvab047.
10
Distinguishable optimal levels of plasma B-type natriuretic peptide in heart failure management based on complicated atrial fibrillation.基于复杂性心房颤动的心力衰竭管理中可区分的血浆B型利钠肽最佳水平
Int Heart J. 2005 May;46(3):453-64. doi: 10.1536/ihj.46.453.

本文引用的文献

1
Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association.《心脏病与卒中统计数据-2023 更新:美国心脏协会报告》。
Circulation. 2023 Feb 21;147(8):e93-e621. doi: 10.1161/CIR.0000000000001123. Epub 2023 Jan 25.
2
Single-Center Study in Lithuania to Evaluate the Role of Transthoracic Impedance Cardiography in the Diagnosis and Outcome Evaluation of 301 Patients with Chronic Heart Failure Exacerbation.立陶宛单中心研究评估了经胸阻抗心动图在 301 例慢性心力衰竭加重患者的诊断和结局评估中的作用。
Med Sci Monit. 2022 Dec 24;28:e938389. doi: 10.12659/MSM.938389.
3
Intersection of atrial fibrillation and heart failure with mildly reduced and preserved ejection fraction in >400 000 participants in the Get With The Guidelines-Heart Failure Registry.
在超过 400000 名 Get With The Guidelines-Heart Failure 注册研究参与者中,心房颤动和心力衰竭与射血分数轻度降低和保留的交集。
Eur J Heart Fail. 2023 Jan;25(1):63-73. doi: 10.1002/ejhf.2729. Epub 2022 Nov 20.
4
In-Hospital Mortality Rate and Predictors of 30-Day Readmission in Patients With Heart Failure Exacerbation and Atrial Fibrillation: A Cross-Sectional Study.心力衰竭加重合并心房颤动患者的院内死亡率及30天再入院预测因素:一项横断面研究
Int J Heart Fail. 2022 Jul 20;4(3):145-153. doi: 10.36628/ijhf.2022.0002. eCollection 2022 Jul.
5
Effects of early phase 1 cardiac rehabilitation on cardiac function evaluated by impedance cardiography in patients with coronary heart disease and acute heart failure.冠心病合并急性心力衰竭患者早期I期心脏康复对经阻抗心动图评估的心脏功能的影响
Front Cardiovasc Med. 2022 Aug 24;9:958895. doi: 10.3389/fcvm.2022.958895. eCollection 2022.
6
Association of Systemic Vascular Resistance Analog and Cardiovascular Outcomes: The Heart and Soul Study.系统血管阻力模拟物与心血管结局的关系:心脏与灵魂研究。
J Am Heart Assoc. 2022 Sep 6;11(17):e026016. doi: 10.1161/JAHA.122.026016. Epub 2022 Aug 24.
7
Rationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2): a randomized, double blind, placebo controlled, single center, phase 2 study.白细胞介素-1 阻断在近期失代偿性心力衰竭(REDHART2)中的作用机制和设计:一项随机、双盲、安慰剂对照、单中心、2 期研究。
J Transl Med. 2022 Jun 15;20(1):270. doi: 10.1186/s12967-022-03466-9.
8
Clinical value of the HATCH score for predicting adverse outcomes in patients with heart failure.HATCH 评分预测心力衰竭患者不良结局的临床价值。
Heart Vessels. 2022 Aug;37(8):1363-1372. doi: 10.1007/s00380-022-02035-w. Epub 2022 Feb 28.
9
Catheter ablation for atrial fibrillation can be safely performed without invasive hemodynamic monitoring: A multi-center study.导管消融治疗心房颤动可以在不进行有创血流动力学监测的情况下安全进行:一项多中心研究。
J Interv Card Electrophysiol. 2022 Sep;64(3):743-749. doi: 10.1007/s10840-022-01151-x. Epub 2022 Feb 19.
10
Echocardiography and impedance cardiography as determinants of successful slow levosimendan infusion in advanced older heart failure patients.超声心动图和阻抗心动图作为高龄晚期心力衰竭患者成功缓慢输注左西孟旦的决定因素
J Geriatr Cardiol. 2021 Dec 28;18(12):1058-1062. doi: 10.11909/j.issn.1671-5411.2021.12.010.